| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ann M Mortimer, Praveen Singh, Charles J Shepherd, Junais Puthiryacka. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world. Clinical schizophrenia & related psychoses. vol 4. issue 1. 2010-09-02. PMID:20643629. |
clozapine for treatment-resistant schizophrenia: national institute of clinical excellence (nice) guidance in the real world. |
2010-09-02 |
2023-08-12 |
Not clear |
| Michael A Sopko, Charles F Cale. Chronic leukocytosis associated with clozapine treatment. Clinical schizophrenia & related psychoses. vol 4. issue 2. 2010-09-02. PMID:20643637. |
clozapine is an important second-generation antipsychotic that is reserved for patients with refractory schizophrenia. |
2010-09-02 |
2023-08-12 |
Not clear |
| Michael A Sopko, Charles F Cale. Chronic leukocytosis associated with clozapine treatment. Clinical schizophrenia & related psychoses. vol 4. issue 2. 2010-09-02. PMID:20643637. |
we report the case of a patient with refractory schizophrenia who is treated with clozapine and who experienced chronic leukocytosis. |
2010-09-02 |
2023-08-12 |
Not clear |
| Dian-zhang Xiong, Ling-ling Liu, Yi-Yan, Ye-Fen. [Observation on the therapeutic effect of electroacupuncture combined with small dose of clozapine in clinical treatment of refractory schizophrenia]. Zhen ci yan jiu = Acupuncture research. vol 35. issue 2. 2010-08-17. PMID:20626147. |
[observation on the therapeutic effect of electroacupuncture combined with small dose of clozapine in clinical treatment of refractory schizophrenia]. |
2010-08-17 |
2023-08-12 |
Not clear |
| Dian-zhang Xiong, Ling-ling Liu, Yi-Yan, Ye-Fen. [Observation on the therapeutic effect of electroacupuncture combined with small dose of clozapine in clinical treatment of refractory schizophrenia]. Zhen ci yan jiu = Acupuncture research. vol 35. issue 2. 2010-08-17. PMID:20626147. |
to observe the effect of electroacupuncture (ea) in combination with small dose of clozapine on clinical symptoms of refractory schizophrenia patients so as to evaluate its validity and security. |
2010-08-17 |
2023-08-12 |
Not clear |
| A Abu-Ake. Phoricity as a measure of Clozaril's efficacy in treating disorganized schizophrenia. Clinical linguistics & phonetics. vol 13. issue 5. 2010-08-13. PMID:20486884. |
certain changes in the conversational ability of individuals with schizophrenia were observed following the introduction of clozaril. |
2010-08-13 |
2023-08-12 |
human |
| Deanna L Kelly, Stephanie Feldman, Douglas L Boggs, Elizabeth Gale, Robert R Conle. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia. Comprehensive psychiatry. vol 51. issue 3. 2010-07-15. PMID:20399340. |
nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia. |
2010-07-15 |
2023-08-12 |
Not clear |
| Arun K Tiwari, Clement C Zai, Olga Likhodi, Annika Lisker, Deepika Singh, Renan P Souza, Poonam Batra, Syed H E Zaidi, Sheng Chen, Fang Liu, Imke Puls, Herbert Y Meltzer, Jeffrey A Lieberman, James L Kennedy, Daniel J Mülle. A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 35. issue 6. 2010-07-12. PMID:20107430. |
twenty tag snps were analyzed in 183 patients who underwent treatment (with either clozapine, olanzapine, haloperidol, or risperidone) for chronic schizophrenia were evaluated for antipsychotic-induced weight gain for up to 14 weeks. |
2010-07-12 |
2023-08-12 |
Not clear |
| Joshua D Vardigan, Sarah L Huszar, Caitlyn H McNaughton, Peter H Hutson, Jason M Uslane. MK-801 produces a deficit in sucrose preference that is reversed by clozapine, D-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: relevance to negative symptoms associated with schizophrenia? Pharmacology, biochemistry, and behavior. vol 95. issue 2. 2010-07-01. PMID:20122952. |
mk-801 produces a deficit in sucrose preference that is reversed by clozapine, d-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator cdppb: relevance to negative symptoms associated with schizophrenia? |
2010-07-01 |
2023-08-12 |
Not clear |
| Herbert Y Meltzer, William V Bobo, Myung A Lee, Philip Cola, Karuna Jayathilak. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia. Psychiatry research. vol 177. issue 3. 2010-07-01. PMID:20378185. |
a randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia. |
2010-07-01 |
2023-08-12 |
Not clear |
| Herbert Y Meltzer, William V Bobo, Myung A Lee, Philip Cola, Karuna Jayathilak. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia. Psychiatry research. vol 177. issue 3. 2010-07-01. PMID:20378185. |
clozapine has been shown to be superior to typical neuroleptic drugs for treating positive symptoms in treatment-resistant (tr) schizophrenia. |
2010-07-01 |
2023-08-12 |
Not clear |
| Herbert Y Meltzer, William V Bobo, Myung A Lee, Philip Cola, Karuna Jayathilak. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia. Psychiatry research. vol 177. issue 3. 2010-07-01. PMID:20378185. |
long-term data from randomized clinical trials comparing clozapine with typical neuroleptics in non-tr schizophrenia are rare. |
2010-07-01 |
2023-08-12 |
Not clear |
| Herbert Y Meltzer, William V Bobo, Myung A Lee, Philip Cola, Karuna Jayathilak. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia. Psychiatry research. vol 177. issue 3. 2010-07-01. PMID:20378185. |
we previously reported that clozapine was superior to typical neuroleptic drugs in some domains of cognition in recent onset non-tr schizophrenia. |
2010-07-01 |
2023-08-12 |
Not clear |
| Herbert Y Meltzer, William V Bobo, Myung A Lee, Philip Cola, Karuna Jayathilak. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia. Psychiatry research. vol 177. issue 3. 2010-07-01. PMID:20378185. |
we now present data on psychopathology and quality of life from this randomized, flexibly dosed, 24-month study of clozapine vs. typical neuroleptics in non-tr schizophrenia patients. |
2010-07-01 |
2023-08-12 |
Not clear |
| Herbert Y Meltzer, William V Bobo, Myung A Lee, Philip Cola, Karuna Jayathilak. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia. Psychiatry research. vol 177. issue 3. 2010-07-01. PMID:20378185. |
clozapine and typical neuroleptic drugs appear to produce equivalent improvement in psychopathology in patients with non-tr schizophrenia. |
2010-07-01 |
2023-08-12 |
Not clear |
| Herbert Y Meltzer, William V Bobo, Myung A Lee, Philip Cola, Karuna Jayathilak. A randomized trial comparing clozapine and typical neuroleptic drugs in non-treatment-resistant schizophrenia. Psychiatry research. vol 177. issue 3. 2010-07-01. PMID:20378185. |
these considerations should be taken into account in decisions of how best to utilize clozapine in the treatment of schizophrenia. |
2010-07-01 |
2023-08-12 |
Not clear |
| Eser Lay Ergün, Bilge Volkan-Salanci, Aygun Ertugrul, Basaran Demir, Belkis Erba. Evaluation of SISCOM in routine regional cerebral blood flow alterations after clozapine, in schizophrenia. Hellenic journal of nuclear medicine. vol 13. issue 1. 2010-06-28. PMID:20411169. |
evaluation of siscom in routine regional cerebral blood flow alterations after clozapine, in schizophrenia. |
2010-06-28 |
2023-08-12 |
Not clear |
| Eser Lay Ergün, Bilge Volkan-Salanci, Aygun Ertugrul, Basaran Demir, Belkis Erba. Evaluation of SISCOM in routine regional cerebral blood flow alterations after clozapine, in schizophrenia. Hellenic journal of nuclear medicine. vol 13. issue 1. 2010-06-28. PMID:20411169. |
we have studied the brain perfusion spet data obtained both before (pre-spet) and 8 weeks after (post-spet) clozapine treatment, in 20 patients with schizophrenia. |
2010-06-28 |
2023-08-12 |
Not clear |
| Hugh M Jones, Lyn S Pilowsk. New targets for antipsychotics. Expert review of neurotherapeutics. vol 2. issue 1. 2010-06-25. PMID:19811016. |
clozapine exhibits superior clinical efficacy in resistant schizophrenia. |
2010-06-25 |
2023-08-12 |
Not clear |
| David C Henderson, Bikash Sharma, Xiaoduo Fan, Paul M Copeland, Christina P Borba, Oliver Freudenreich, Corinne Cather, A Eden Evins, Donald C Gof. Dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists. vol 22. issue 1. 2010-06-24. PMID:20196981. |
dietary saturated fat intake and glucose metabolism impairments in nondiabetic, nonobese patients with schizophrenia on clozapine or risperidone. |
2010-06-24 |
2023-08-12 |
Not clear |